Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD =: 11.32, 95% CI = [: 14.51,: 8.41], P < 0.00001), low-density lipoprotein cholesterol level (WMD =: 4.83, 95% CI = [: 7.52,: 2.14], P=0.0004), and triglyceride level (WMD =: 8.23, 95% CI = [: 13.08,: 3.38], P=0.0009, but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD =: 0.32, 95%CI = [: 1.24, 0.60], P=0.50).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Source: Article title.
Publisher article type: review-article
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Review / evidence synthesis · International Journal of Endocrinology · 2021
Original publication title
The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Copyright © 2021 Hong Gao et al.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome.
Source: PurposeAbstract: What methods does the paper describe?
PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases were searched up to May 2020, to identify randomized controlled trials of the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. The Cochrane risk of bias tool was applied to assess the risk of bias, and RevMan5.3 software was used for statistical analysis.
Source: MethodsAbstract: Results
Ten studies were included in this study, including 543 subjects. The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD =: 11.32, 95% CI = [: 14.51,: 8.41], P < 0.00001), low-density lipoprotein cholesterol level (WMD =: 4.83, 95% CI = [: 7.52,: 2.14], P=0.0004), and triglyceride level (WMD =: 8.23, 95% CI = [: 13.08,: 3.38], P=0.0009, but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD =: 0.32, 95%CI = [: 1.24, 0.60], P=0.50).
Source: ResultsAbstract: Conclusion
Vitamin D supplementation can significantly reduce total cholesterol, low-density lipoprotein cholesterol, and triglycerides in patients with polycystic ovary syndrome. However, it has no significant effect on high-density lipoprotein cholesterol.
Source: ConclusionAuthors’ abstract
Purpose
Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome.
Methods
PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases were searched up to May 2020, to identify randomized controlled trials of the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. The Cochrane risk of bias tool was applied to assess the risk of bias, and RevMan5.3 software was used for statistical analysis.
Results
Ten studies were included in this study, including 543 subjects. The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD =: 11.32, 95% CI = [: 14.51,: 8.41], P < 0.00001), low-density lipoprotein cholesterol level (WMD =: 4.83, 95% CI = [: 7.52,: 2.14], P=0.0004), and triglyceride level (WMD =: 8.23, 95% CI = [: 13.08,: 3.38], P=0.0009, but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD =: 0.32, 95%CI = [: 1.24, 0.60], P=0.50).
Conclusion
Vitamin D supplementation can significantly reduce total cholesterol, low-density lipoprotein cholesterol, and triglycerides in patients with polycystic ovary syndrome. However, it has no significant effect on high-density lipoprotein cholesterol.
Publication and source details
Original title: The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Hong Gao; YanTao Li; WenNan Yan; Fei Gao
International Journal of Endocrinology · 2021
Academic Editor: Antonio Simone Laganà
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T14:34:34.906943+00:00
DOI: 10.1155/2021/8849688 · PMC7868162